日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Circulating tumor cells (CTCs) enumeration and machine-learning based diagnostic biomarkers for breast cancer detection

循环肿瘤细胞(CTC)计数和基于机器学习的乳腺癌检测诊断生物标志物

Liu, Chun-Yu; Lin, Yu-Hsiang; Tsai, Yi-Fang; Lu, Po-Yen; Chen, Ji-Lin; Li, Yu-Hsuan; Huang, Chi-Cheng; Lin, Yen-Shu; Chao, Ta-Chung; Feng, Chin-Jung; Hsu, Chih-Yi; Chiu, Jen-Hwey; Chen, Chyong-Mei; Tseng, Ling-Ming

Optimizing Systemic Therapy for Advanced Sarcomas: Outcomes With Gemcitabine, Docetaxel, Cisplatin, and Everolimus in a Retrospective Single-Center Study

优化晚期肉瘤全身治疗:回顾性单中心研究中吉西他滨、多西他赛、顺铂和依维莫司联合治疗的疗效

Wu, Wen-Chi; Ho, I-Wei; Chen, San-Chi; Chen, Paul Chih-Hsueh; Wu, Po-Kuei; Chen, Chao-Ming; Wu, Hung-Ta; Lin, Chung-Jung; Chao, Ta-Chung; Yen, Chueh-Chuan

Exploring the Use of Boron Neutron Capture Therapy for Recurrent Breast Cancer and Brain Metastases: A Case Series

探索硼中子俘获疗法在复发性乳腺癌和脑转移瘤治疗中的应用:病例系列研究

Liao, Hung-Ruei; Chen, Yi-Wei; Hsieh, Chen-Hsi; Chao, Ta-Chung; Lin, Ko-Han; Peir, Jinn-Jer; Chou, Fong-In; Huang, Pin-I

Circulating T-cell receptor repertoire and clinicopathological correlations in breast cancer patients: immune repertoire analysis from the VGH-TAYLOR study

乳腺癌患者循环T细胞受体库及其与临床病理的相关性:来自VGH-TAYLOR研究的免疫库分析

Tseng, Ling-Ming; Huang, Chi-Cheng; Chen, Ji-Lin; Tsai, Yi-Fang; Chao, Ta-Chung; Wu, Wen-Chi; Lien, Pei-Ju; Lin, Yen-Shu; Feng, Chin-Jung; Chen, Yen-Jen; Lai, Jiun-I; Chiu, Jen-Hwey; Hsu, Chih-Yi; Liu, Chun-Yu

Survival analysis of adjuvant endocrine therapy in HER2 positive early breast cancer patients with low ER positivity

HER2阳性早期乳腺癌低ER阳性患者辅助内分泌治疗的生存分析

Yu, Hsuan-Hsuan; Gracia, Deanna; Chao, Ta-Chung; Ho, Chan-Heng; Chen, Hao-Yang; Tseng, Ling-Ming; Huang, Chi-Cheng

Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: prognostic effect of proton pump inhibitor use

CDK4/6抑制剂在激素受体阳性转移性乳腺癌中的真实世界评价:质子泵抑制剂使用对预后的影响

Chen, Bo-Fang; Lai, Jiun-I; Tsai, Yi-Fang; Lien, Pei-Ju; Lin, Yen-Shu; Feng, Chin-Jung; Chen, Yen-Jen; Cheng, Han-Fang; Chao, Ta-Chung; Liu, Chun-Yu; Tseng, Ling-Ming; Huang, Chi-Cheng

Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by Immunohistochemistry

免疫组织化学法检测HER2阳性及结果不确定乳腺癌的基因改变

Tsai, Yi-Fang; Hsu, Chih-Yi; Chiu, Yun-Ning; Huang, Chi-Cheng; Chou, Shih-Hsiang; Lin, Yen-Shu; Chao, Ta-Chung; Liu, Chun-Yu; Chiu, Jen-Hwey; Tseng, Ling-Ming

Addition of Bevacizumab to Vinorelbine-Platinum combination is efficacious in Heavily Pretreated HER2-Negative Metastatic Breast Cancer

在既往接受过大量治疗的HER2阴性转移性乳腺癌中,贝伐珠单抗联合长春瑞滨-铂类药物治疗有效。

Ho, I-Wei; Tseng, Yi-Ru; Liu, Chun-Yu; Tsai, Yi-Fang; Huang, Chi-Cheng; Tseng, Ling-Ming; Chao, Ta-Chung; Lai, Jiun-I

Survival outcomes in trial defined high-risk hormone receptor-positive/human epidermal growth factor receptor II-negative early breast cancer: impact of adjuvant chemotherapy

试验定义的激素受体阳性/人表皮生长因子受体II阴性高危早期乳腺癌患者的生存结果:辅助化疗的影响

Chao, Ta-Chung; Gracia, Deanna; Ho, Chan-Heng; Chen, Hao-Yang; Huang, Chi-Cheng; Tseng, Ling-Ming

Correlation Between PIK3R1 Expression and Cell Growth in Human Breast Cancer Cell Line BT-474 and Clinical Outcomes

PIK3R1表达与人乳腺癌细胞系BT-474细胞生长及临床结果的相关性

Tsai, Yi-Fang; Lai, Jiun-I; Liu, Chun-Yu; Hsi, Chieh-Ning; Hsu, Chih-Yi; Huang, Chi-Cheng; Feng, Chin-Jung; Lin, Yen-Shu; Chao, Ta-Chung; Chiu, Jen-Hwey; Tseng, Ling-Ming